Bukwang Pharm (003000) — Cash Flow-to-Debt Ratio
Bukwang Pharm (003000) has a Cash Flow-to-Debt Ratio of -0.05x as of September 2025, meaning its operating cash flow of ₩-6.24 Billion could theoretically repay 0% of its total liabilities (₩132.16 Billion) in one year. Explore Bukwang Pharm long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bukwang Pharm Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Bukwang Pharm across 13 annual periods. Also explore 003000 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Bukwang Pharm (2007–2024)
Year-by-year debt coverage analysis for Bukwang Pharm. For market capitalisation and broader financial context, see 003000 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | ₩34.36 Billion | ₩129.03 Billion | ▲ +654.0% |
| 2023 | -0.05x | ₩-9.36 Billion | ₩194.75 Billion | ▼ -137.7% |
| 2022 | 0.13x | ₩16.46 Billion | ₩129.08 Billion | ▼ -43.6% |
| 2021 | 0.23x | ₩26.52 Billion | ₩117.36 Billion | ▲ +3956.1% |
| 2020 | 0.01x | ₩723.17 Million | ₩129.78 Billion | ▲ +101.5% |
| 2019 | -0.38x | ₩-23.41 Billion | ₩62.05 Billion | ▼ -543.7% |
| 2018 | 0.09x | ₩6.82 Billion | ₩80.17 Billion | ▼ -75.2% |
| 2017 | 0.34x | ₩8.56 Billion | ₩24.93 Billion | ▲ +201.8% |
| 2016 | -0.34x | ₩-7.76 Billion | ₩23.00 Billion | ▼ -193.4% |
| 2015 | 0.36x | ₩10.30 Billion | ₩28.51 Billion | ▼ -65.2% |
| 2014 | 1.04x | ₩27.86 Billion | ₩26.82 Billion | ▼ -22.8% |
| 2013 | 1.35x | ₩36.52 Billion | ₩27.14 Billion | ▲ +114.3% |
| 2007 | 0.63x | ₩27.87 Billion | ₩44.39 Billion | — |